A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting where good ideas are being implemented, it encourages their wider uptake.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Overall ranking Vaccines Funding Methodology Key Finding

In the media

Read how the global media covers how pharmaceutical companies respond to market trends and global health issues using the Foundation's research, and translates the complexity of access to medicine for the public.

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

20 Jan 2017

A Helping Hand

In the article, Viveka Roychowdhury refers to the performance of the companies in the 2016 Access to Medicine Index, and interviews Jayasree K. Iyer,...

01 Dec 2016

Accessing Big Pharma’s Conscience

The Medicine Maker interviews Jayasree K. Iyer for their December issue. In the interview, Jayasree discusses the Access to Medicine Foundation, the A...

29 Nov 2016

Speeding up access to medicine for developing countries

Nikkan Kogyo publishes article on the 2016 Access to Medicine Index

25 Nov 2016

Delivery strategies rank high for Big Pharma, now

In the article titled ‘Delivery strategies rank high for Big Pharma, now’, Jyothi Datta writes about the performance of pharma companies in the 2016 A...

23 Nov 2016

NOS 1 covers 2016 Index, interviews Jayasree K. Iyer

Dutch national news channel NOS 1 covers the publication of the 2016 Access to Medicine Index. Interviewed for the item, Jayasree K. Iyer highlig...

23 Nov 2016

Suzanne Wolf discusses new 2016 Access to Medicine Index on NOS Radio 1 Journaal

Dutch national news radio covers the findings of the fifth Access to Medicine Index, published on 14 November, 2016 (Dutch language). 

22 Nov 2016

Africa 54 talks to Jayasree K Iyer about pharma activities in Africa

Linord Moudou of Africa 54 on Voice of America  talks to Jayasree K. Iyer. She describes trends in how pharmaceutical companies approach mar...

17 Nov 2016

Access to Medicine Index says industry is making ‘moderate progress’

The Pharmaceutical Journal reports on the industry-level findings from the 2016 Access to Medicine Index, including on progress in pro-access licensin...

14 Nov 2016

Big pharma is failing to do enough for poor countries

Gonzalo Viña covers the 2016 Access to Medicine Index for the Financial Times. He focuses on the companies ranked in the lower half of the Index, and...

14 Nov 2016

GSK tops list of drug firms improving global access to medicine

Julia Kollewe reports on how GSK can lead the Access to Medicine Index for the fifth time in 2016, while its British peer AstraZeneca climbs into the...

14 Nov 2016

Drug firms need to tackle affordability

Anne Gulland reports on the 2016 Access to Medicine Index for the BMJ, covering the ranking itself and the main findings from the Index report.

14 Nov 2016

Pharmaindustrie tut zu wenig in der Dritten Welt

Patrick Griesser reports on the 2016 Access to Medicine Index, focusing on affordability and R&D pipelines (article in German).

14 Nov 2016

Drugmakers improve access for poor, GSK ranked top

Ben Hirschler and Mark Potter report on the 2016 Access to Medicine Index for Reuters, highlighting how the Index can focus executives’ attention on t...

14 Nov 2016

Volop kansen voor farmaceutische bedrijven in arme landen

Henk Snyders reports on the 2016 Access to Medicine Index, with a focus on affordability of medicines (article in Dutch).

14 Nov 2016

Grote farmaceuten doen meer voor armen

Ellen de Visser reports on the 2016 Access to Medicine Index (article in Dutch).

14 Nov 2016

Pharmaindustrie engagiert sich mehr in Entwicklungsländern

Writing for WirtschaftsWoche, Germany's weekly business magazine, Jürgen Salz reports on the results of the 2016 Access to Medicine Index. T...

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.